Safety of an Intravitreal Bevacizumab Biosimilar ( <scp>MVASI</scp> )
Intravitreal MVASI had a similar ophthalmic safety profile and may be used as an alternative to Avastin.
Authors
- Devaraj Supramaniam
- Sonia Huang (ORCID: https://orcid.org/0000-0002-6716-710X)
- Stewart Lake (ORCID: https://orcid.org/0000-0003-0078-3319)
- Bobak Bahrami (ORCID: https://orcid.org/0000-0003-1057-5142)
- Hanru Wang
- Matthew Little
- Sudha Cugati
- Marzieh Tahmasebi Sarvestani (ORCID: https://orcid.org/0000-0002-0222-0547)
- Weng Onn Chan
Institutions
- Royal Adelaide Hospital (AU)
- Modbury Hospital (AU)
- Flinders Medical Centre (AU)
- Queen Elizabeth Hospital (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- Clinical and Experimental Ophthalmology
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1111/ceo.14515
- Citations
- 5
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.54